Design, construction and testing of a low-cost automated 68Gallium-labeling synthesis unit

News & Updates
I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font.



- Jun 18, 2021
Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without MoCo
- Jun 18, 2021
18 F-Fluciclovine PET in Men With BCR PCa after Prostatectomy and planning for Salvage Radiation


- Jun 18, 2021
18 F-FES PET/CT Measurement of ER Suppression during a Phase I Trial of GDC-0810


- Jun 18, 2021
C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease

- Jun 18, 2021
Clinical impact of PET/MR in treated colorectal cancer patients

- Jun 18, 2021
Management implications of FDG PET/MR in untreated intrahepatic cholangiocarcinoma


- Jun 18, 2021
A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases

- Jun 18, 2021
Improving staging of rectal cancer in the pelvis: the role of PET/MRI

- Jun 18, 2021
PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analys

- Jun 18, 2021
Evaluation of the Diagnostic Performance of PET/MR for the Diagnosis of Liver Metastases


- Jun 16, 2021
The Impact of PET with 18F-Fluciclovine on the Treatment of BCR of PCa: Results from the LOCATE Tria


- Jun 16, 2021
Multitargeted TKI produces discordant changes between 99mTc-MDP bone scans and other biomarkers


- Jun 16, 2021
Prospective trial with optical molecular imaging for percutaneous interventions in hepatic lesions


- Jun 16, 2021
Pilot Clinical Trial of Indocyanine Green Fluorescence-Augmented Colonoscopy in High Risk Patients

- Jun 15, 2021
Performance of fluciclovine PET/MR in the evaluation of osseous metastases from CRPC

- Jun 15, 2021
Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma


- Jun 15, 2021
Baseline TLG measured with FDG PET/CT as a predictor of PFS in DLBCL


- Jun 15, 2021
A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68 Ga-DOTATOC